Trials / Not Yet Recruiting
Not Yet RecruitingNCT07291375
Role of Amlodipine in Reduction of CIN
The Effect of Low Dose Oral Amlodipine in Renal Protection From Contrast Induced Nephropathy in Diabetic Patients in Intensive Care Unit
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium channel blocker | amlodipine group will receive low dose oral amlodipine ( 5 mg ) before iv contrast and every 12 hour for 48 hour |
| OTHER | Hydration | before the procedure patients will recieve iv bolus of 250 ml saline followed by continous infusion of 100 ml/h of normal saline |
Timeline
- Start date
- 2025-12-20
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2025-12-18
- Last updated
- 2025-12-18
Source: ClinicalTrials.gov record NCT07291375. Inclusion in this directory is not an endorsement.